Companies: 10,795·Total market cap: $144.5T
Edwards Lifesciences Corporation

Edwards Lifesciences Corporation

EWNYSEHealthcare● Active
$85.96
$-1.49(-1.70%)
Market Cap$49.5B
P/E Ratio
52W High$89.445
52W Low$72.3
Overview

Edwards Lifesciences Corporation (EW) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

EW · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $1.07B for FY2025 (fiscal year ending 2025-12-31), down 74.3% year-over-year. Net profit margin was 17.7%. Based on available data, Edwards Lifesciences Corporation has been profitable since at least 2011.

FY2025 Net Income$1.07B▼ -74.3% YoY
Trailing 12M (TTM)$1.09Btrailing 4 quarters sum
Net Profit Margin17.7%$1.07B ÷ $6.07B
YoY Change-74.3%
5-Year CAGR+5.5%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · EW net income history · EW profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$1.07B▼ 74.3%17.7%
FY2024$4.17B▲ +197.7%76.8%
FY2023$1.40B▼ 7.9%28.0%
FY2022$1.52B▲ +1.3%28.3%
FY2021$1.50B▲ +82.5%28.7%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Edwards Lifesciences Corporation
Edwards Lifesciences CorporationYOU
EW
$1.07B-74.3%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Edwards Lifesciences Corporation (EW) reported net income of $1.07B for FY2025 (fiscal year ending 2025-12-31), down 74.3% year-over-year. The net profit margin was 17.7% — meaning the company kept $0.18 of every dollar of revenue as profit.

Based on available data, Edwards Lifesciences Corporation has been profitable since at least 2011. Net income reached a peak of $4.17B in FY2024. Data available for 15 fiscal years.

Edwards Lifesciences Corporation's net profit margin was 17.7% for FY2025, based on the latest annual results.

Investors sometimes search for "Edwards Lifesciences Corporation net worth" — the company's market capitalization is a separate figure from EW net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

EW net income · 5 questions

Edwards Lifesciences Corporation is profitable. The company reported net income of $1.07B for FY2025, a net profit margin of 17.7%. Net income was down 74.3% year-over-year. Based on available data, Edwards Lifesciences Corporation has been profitable since at least 2011.

is EW profitabledoes EW make a profitEW profitabilityEW profitable company

Source: FMP /income-statement · GAAP · Edwards Lifesciences Corporation · Edwards Lifesciences Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026